- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Sox2 promotes tamoxifen resistance in breast cancer cells ; volume:6 ; number:1 ; year:2014 ; pages:66-79 ; extent:14
EMBO molecular medicine / European Molecular Biology Organization ; 6, Heft 1 (2014), 66-79 (gesamt 14)
- Creator
-
Piva, Marco
Domenici, Giacomo
Iriondo, Oihana
Rábano, Miriam
Simões, Bruno M.
Comaills, Valentine
Barredo, Inmaculada
López‐Ruiz, Jose A.
Zabalza, Ignacio
Kypta, Robert
Vivanco, Maria d. M.
- DOI
-
10.1002/emmm.201303411
- URN
-
urn:nbn:de:101:1-2023011307302602031137
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Piva, Marco
- Domenici, Giacomo
- Iriondo, Oihana
- Rábano, Miriam
- Simões, Bruno M.
- Comaills, Valentine
- Barredo, Inmaculada
- López‐Ruiz, Jose A.
- Zabalza, Ignacio
- Kypta, Robert
- Vivanco, Maria d. M.
Other Objects (12)
Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
AFF3 upregulation mediates tamoxifen resistance in breast cancers
Overexpression of COL11A1 confers tamoxifen resistance in breast cancer
Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
AFF3 upregulation mediates tamoxifen resistance in breast cancers
Overexpression of COL11A1 confers tamoxifen resistance in breast cancer
Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
AFF3 upregulation mediates tamoxifen resistance in breast cancers
Overexpression of COL11A1 confers tamoxifen resistance in breast cancer
Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer